Welcome to our dedicated page for Nakamoto SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kindly MD, Inc. (NAKA) SEC filings page provides access to the company’s official regulatory disclosures as a publicly traded issuer. KindlyMD, a patient-first and healthcare data company with integrated healthcare services and a Bitcoin treasury strategy via its subsidiary Nakamoto Holdings Inc., uses filings with the U.S. Securities and Exchange Commission to report material events, corporate actions, and financial information.
Among the key documents available are Current Reports on Form 8-K, which the company uses to disclose significant developments. Recent 8-K filings have addressed topics such as the completion of the merger with Nakamoto, entry into and termination of material loan agreements secured by Bitcoin or other digital assets, authorization of a share repurchase program, receipt of a Nasdaq minimum bid price notice, and the establishment of dates and record dates for annual shareholder meetings. These filings also cover matters like redemption of a secured convertible debenture and the company’s financing arrangements with lenders focused on digital assets.
Investors can also review proxy materials, including the Definitive Proxy Statement on Schedule 14A, which outlines proposals submitted to stockholders, such as the election of directors, approval of converting Kindly MD from a Utah corporation to a Delaware corporation, ratification of the independent registered public accounting firm, and potential adjournment of the annual meeting. Notifications of late filing on Form 12b-25 (NT 10-Q) provide context when additional time is needed to complete quarterly reports, including explanations related to the accounting complexity of the merger with Nakamoto.
On Stock Titan, these filings are complemented by AI-powered tools that help summarize lengthy documents and highlight key points, such as new financing obligations, changes in capital structure, or updates on the company’s Bitcoin treasury strategy. Users can quickly locate information about quarterly and annual reporting, material agreements, shareholder votes, and listing status, as well as track how KindlyMD’s integrated healthcare operations and Bitcoin-focused activities are reflected in its regulatory record.
David Bailey, Chairman and CEO of Nakamoto Inc., filed a Schedule 13D reporting beneficial ownership of 119,361,200 shares of common stock, representing 17.33% of the class, based on 688,942,624 shares outstanding as of February 26, 2026.
Bailey’s stake comes from several transactions: the Nakamoto merger (11,160,572 shares), the UTXO merger (11,916,837 shares), the BTC merger (96,283,791 shares), and 751,879 RSUs granted under a consulting agreement. He holds sole voting and dispositive power over these shares.
Bailey states he holds the securities for long‑term investment but may buy or sell more in the future. His shares are subject to lock‑up agreements tied to the Nakamoto, UTXO, and BTC mergers, and he benefits from registration rights that can support future registered sales, including potential underwritten offerings of at least $25 million.
Nakamoto Inc. Schedule 13G shows that Calli Sullivan Bailey beneficially owns 109,959,346 shares of Common Stock, representing 15.96% of the class, as reported in the filing signed 02/26/2026. The filing also reports 6,600,889 shares held of record by the reporting person's spouse, for which the reporting person disclaims beneficial ownership.
Nakamoto Inc. disclosed that investor Bailey Calli Sullivan is a beneficial owner of more than ten percent of the company’s stock. The Form 3 filing reports direct ownership of 109,959,346 shares of common stock as of February 20, 2026, establishing this large existing position.
Nakamoto Inc. files a prospectus supplement registering 2,059,811 shares of common stock issuable upon exercise of previously issued warrants and the resale of 82,310 shares of common stock.
The supplement states the company is not selling any shares and will receive proceeds only if the warrants are exercised for cash. The supplement incorporates a Current Report on Form 8-K describing the completed mergers with BTC and UTXO, the issuance of merger consideration, and updated capitalization: 683,451,950 shares outstanding and 890,148,039 fully diluted shares outstanding as of February 25, 2026.
Nakamoto Inc. completed stock-for-stock acquisitions of BTC Inc. and UTXO Management GP, LLC, issuing and assuming in total 364,795,104 Nakamoto common shares valued at approximately $81.6 million based on a $0.248 share price. BTC holders received 259,886,237 shares plus 78,427,012 shares reserved for assumed BTC options, while UTXO holders received 26,481,860 shares, with portions of both consideration packages held back for post-closing adjustments and indemnities.
The deals add businesses that together generated about $80.5 million in revenue, $34.2 million in EBITDA, and $40.1 million in net income in the 12 months ended September 30, 2025. As of February 25, 2026, common shares outstanding were 683,451,950 and fully diluted shares were 890,148,039. Key insiders now hold significant stakes, including D. Bailey at 17.46%, C. Bailey at 14.47%, and Evans at 6.44%, with their merger shares subject to lock-up agreements for up to 12 months.
Nakamoto Inc. Chief Investment Officer Evans Tyler Matthew reported multiple equity awards. On February 20, 2026, he acquired stock options labelled as grants or awards, including one for 12,491,284 stock options with a per-share exercise relationship of one option for one share of common stock.
On the same date, he also acquired 17,841,993 shares of common stock at a stated price of $0.00 per share, described as received under two separate merger agreements involving BTC Inc. and UTXO Management GP, LLC. Certain fully vested options were assumed by Nakamoto Inc. pursuant to one of these merger agreements.
Nakamoto Inc. reported that Chief Executive Officer and 10% owner Bailey David F acquired 108,200,628 shares of Common Stock on February 20, 2026 as a grant or award transaction at a reported price of $0.0000 per share, leaving him with 119,361,200 shares held directly.
According to the footnote, these shares were received in connection with two merger agreements dated February 16, 2026, involving BTC Inc. and UTXO Management GP, LLC, through which Bailey received shares of Nakamoto Inc. in exchange for interests tied to those entities.
Nakamoto Inc. reported that Chief Commercial Officer Creighton Andrew John acquired 1,685,500 stock options on February 20, 2026 through a grant or award. According to the footnote, these options are fully vested and exercisable on a one-for-one basis for Nakamoto Inc. common stock. The options were assumed by Nakamoto Inc. under an Agreement and Plan of Merger dated February 16, 2026, and following this grant he holds 1,685,500 options directly.
Nakamoto Inc. filed a Regulation FD update after its CEO discussed pending acquisitions of BTC Inc. and UTXO Management GP, LLC on an X Space hosted by Bitcoin Magazine. During that event he loosely described the targets’ combined revenue as “over roughly $100 million.”
Using preliminary unaudited figures for the 12 months ended December 31, 2025, Nakamoto now states that BTC and UTXO actually generated $78 million of combined revenue. It also discloses a non-GAAP profitability metric for an earlier period: based on preliminary unaudited results for the 12 months ended September 30, 2025, the combined EBITDA of BTC and UTXO was $34,180,486.
The company explains how it defines EBITDA and presents it as a supplemental, non-GAAP measure alongside a reconciliation from GAAP net income. The filing also reiterates extensive forward-looking statement language and risks related to closing and integrating the mergers and to Bitcoin market volatility.
Alyeska Investment Group and related parties have disclosed a significant passive stake in Kindly MD, Inc. According to this Schedule 13G, Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh beneficially own 25,612,676 shares of Kindly MD common stock.
This position represents 5.93% of Kindly MD’s outstanding common shares, based on 431,653,091 shares outstanding as reported in the company’s Form 8-K filed on December 18, 2025. The filers certify that the shares were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of the company.